TipRanks
Go Ultimate55% OFF

Pharma Mar SA (PHM1N) Stock Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

PHM1N Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Pharma Mar SA in the past 3 months

PHM1N Stock 12 Month Forecast

MXN 2,097.89▲(17.80% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Pharma Mar SA in the last 3 months. The average price target is MXN 2,097.89 with a high forecast of MXN 2,097.89 and a low forecast of MXN 2,097.89. The average price target represents a 17.80% change from the last price of MXN 1,780.91.
Highest Price TargetMXN 2,097.89Average Price TargetMXN 2,097.89Lowest Price TargetMXN 2,097.89

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:PHM1N
Price TargetFollowArticle
Chardan CapitalMXN 2,097.89buy17.80%UpsideReiterated08/09/26
BTIGMXN 2,538.44buy42.54%UpsideInitiated04/23/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
OVIDOvid Therapeutics
REPLReplimune Group
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Pharma Mar SA

3 Months
Keay Nakae
Keay NakaeChardan Capital
Success Rate3/7 ratings generated profit
43%
Average Return
+8.14%

Copying Keay Nakae's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +8.14% per trade.

1 Year
Keay Nakae
Keay NakaeChardan Capital
Success Rate3/7 ratings generated profit
43%
Average Return
+9.13%

Copying Keay Nakae's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of +9.13% per trade.

2 Years
Keay Nakae
Keay NakaeChardan Capital
Success Rate2/7 ratings generated profit
29%
Average Return
+0.69%

Copying Keay Nakae's trades and holding each position for 2 Years would result in 28.57% of your transactions generating a profit, with an average return of +0.69% per trade.

PHM1N Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for PHM1N
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy23110
Hold00000
Sell00000
Strong Sell00000
total23110

In the current month, PHM1N has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHM1N average Analyst price target in the past 3 months is 2,097.89.

PHM1N Financial Forecast

MXN -12MXN 8.5MXN 29MXN 49.5MXN 70Q1 2026Q3 2026Q4 2026
HighMXN 40.70
ConsensusMXN 20.62
LowMXN -10.70

PHM1N Earnings Forecast

Next quarter’s earnings estimate for PHM1N is MXN 20.62 with a range of -MXN 10.70 to MXN 40.70. The previous quarter’s EPS was MXN 9.86. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

MXN 715.4MMXN 1BMXN 1.3BMXN 1.6BMXN 1.9BQ1 2026Q3 2026Q4 2026
HighMXN 1.78B
ConsensusMXN 1.29B
LowMXN 715M

PHM1N Sales Forecast

Next quarter’s sales forecast for PHM1N is MXN 1.29B with a range of MXN 715.38M to MXN 1.78B. The previous quarter’s sales results were MXN 1.14B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

PHM1N Stock Forecast FAQ

What is MX:PHM1N’s average 12-month price target, according to analysts?
Based on analyst ratings, Pharma Mar SA’s 12-month average price target is Mex$2,097.89.
What is MX:PHM1N’s upside potential, based on the analysts’ average price target?
Pharma Mar SA has 17.80% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Pharma Mar SA a Buy, Sell or Hold?
Pharma Mar SA has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Pharma Mar SA’s share price target?
The average share price target for Pharma Mar SA is Mex$2,097.89. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$2,097.89, and the lowest forecast is Mex$2,097.89. The average share price target represents a 17.80% increase from the current price of Mex$1,780.91.
What do analysts say about Pharma Mar SA?
Pharma Mar SA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Pharma Mar SA?
To buy shares of MX:PHM1N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.